Larvol Delta - Cognition-Therapeutics-Closes-30-Million-Registered-Direct-Offering-to-Two-New-Fundamental-Institutional-Investors-Including-a-Preeminent-Global-Investment-Firm-to-Support-Phase-3-Development-of-Zervimesine-CT1812

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2025/09/02/3143120/0/en/Cognition-Therapeutics-Closes-30-Million-Registered-Direct-Offering-to-Two-New-Fundamental-Institutional-Investors-Including-a-Preeminent-Global-Investment-Firm-to-Support-Phase-3-.html

Sep 2, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next